PaxMedica, Inc.

PaxMedica is a clinical-stage biopharmaceutical company focused on developing innovative treatments for unmet needs in neurodevelopmental disorders. Their lead programs are focused on two of the world’s most challenging conditions – Autism Spectrum Disorder (ASD) and Fragile X-Associated Tremor/Ataxia (FXTAS). There are no FDA-approved treatments for the core symptoms of ASD and no FDA-approved…More treatments at all for FXTAS. They are on a promising path to change that.